AZD-1222/elasomeran/tozinameranRetinal vein occlusion

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2012卷 / 1期

关键词：

D O I：

10.1007/s40278-024-60729-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：66 / 66

相关论文

共 50 条

[21] Azd-1222/elasomeran/tozinameranAcute myocarditis: 5 case reports
Reactions Weekly, 2023, 1955 (1) : 92 - 92
[22] AZD-1222/elasomeran/tozinameranVarious toxicities: 5 case reports
Reactions Weekly, 2022, 1899 (1) : 83 - 83
[23] Azd-1222/elasomeran/tozinameranIgA vasculitis: 12 case reports
Reactions Weekly, 2023, 1970 (1) : 69 - 69
[24] Azd-1222/elasomeran/tozinameranBullous Pemphigoid : 21 case reports
Reactions Weekly, 2023, 1954 (1) : 105 - 105
[25] AZD-1222/elasomeran/tozinameranVarious toxicities: 10 case reports
Reactions Weekly, 2023, 1973 (1) : 59 - 59
[26] AZD-1222/elasomeran/tozinameranImmediate and delayed hypersensitivity: 16 case reports
Reactions Weekly, 2022, 1914 (1) : 109 - 109
[27] AZD-1222/elasomeran/tozinameranMinimal change disease: 4 case reports
Reactions Weekly, 2022, 1927 (1) : 123 - 123
[28] Azd-1222/elasomeran/tozinameranDermatomyositis and dermatomyositis worsening : 5 case reports
Reactions Weekly, 2023, 1940 (1) : 101 - 101
[29] AZD-1222/elasomeran/tozinameranPeri-myocarditis: 27 case reports
Reactions Weekly, 2023, 1946 (1) : 107 - 107
[30] Azd-1222/elasomeran/tozinameranAtopic dermatitis flare: 11 case reports
Reactions Weekly, 2022, 1909 (1) : 123 - 123

← 1 2 3 4 5 →